V. Alfieri (Parma (PR), Italy), H. Parfrey (Cambridge (Cambridgeshire), United Kingdom), M. Bonifazi (Ancona (AN), Italy)
Follistatin-like 1 promotes intermittent hypoxia-induced lung fibroblast activation in vitro and in vivo
L. Xu (Tianjin, China), J. Cao (T, China)
|  |
Micro Array screening of microRNA markers of interstitial lung diseases for differential diagnostics.
G. Shepelkova (Moscow, Russian Federation), A. Zaytseva (Moscow, Russian Federation), V. Evstifeev (Moscow, Russian Federation), I. Stepanyan (Moscow, Russian Federation), E. Shmelev (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation)
| |
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis
N. Lanzarone (Siena, Italy), V. Alonzi (Siena, Italy), L. Bergantini (Siena, Italy), F. Bianchi (Siena, Italy), M. D'Alessandro (Siena, Italy), P. Rottoli (Siena, Italy), R. Refini (Siena, Italy), M. Pieroni (Siena, Italy), E. Bargagli (Siena, Italy), M. Mazzei (Siena, Italy), F. Gentili (Siena, Italy), P. Sestini (Siena, Italy)
| |
Specific serum immunoglobulins G (IgGs) may serve as pointers towards inhalation antigen exposure in patients with hypersensitivity pneumonitis (HP) and uncertain exposure source.
M. Šterclová (Prague, Czech Republic), P. Sojka (Prague, Czech Republic), N. Kaspríková (Prague, Czech Republic), M. Vašáková (Prague, Czech Republic)
| |
Occupational dust exposure as a risk factor for MPO-ANCA-positive interstitial pneumonia
N. SAKUMA (TOKYO, Japan), H. Tojima (TOKYO, Japan), T. Hiroishi (TOKYO, Japan), T. Matsumura (TOKYO, Japan), C. Koumura (TOKYO, Japan), M. Kouno (TOKYO, Japan)
|  |
Interstitial lung disease associated with ANCA positivity: a retrospective analysis
S. Juman (Manchester, United Kingdom), S. Haque (Manchester, United Kingdom), N. Chaudhuri (Manchester, United Kingdom)
| |
The prevalence of bronchitis and associations with spirometry in patients with interstitial lungdisease in a Canadian tertiary care centre
T. Ho (Hamilton, Canada), C. Scallan (Hamilton, Canada), N. Hambly (Hamilton, Canada), G. Cox (Hamilton, Canada), M. Kolb (Hamilton, Canada), P. Nair (Hamilton, Canada)
| |
Correlations of endomicroscopic and high-resolution computer tomography patterns in patients with interstitial lung diseases
O. Danilevskaya (Moscow, Russian Federation), A. Averyanov (Moscow, Russian Federation), V. Lesnyak (Moscow, Russian Federation)
| |
Risk factors of interstitial lung diseases in patients with rheumatoid arthritis.
E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation), Y. Shoykhet (Barnaul, Russian Federation), V. Elykomov (Barnaul, Russian Federation), V. Yarkova (Tyumen, Russian Federation), A. Berdyugina (Barnaul, Russian Federation), E. Mukhtarova (Yoshkar-Ola, Russian Federation)
| |
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
F. Rampp (Munich, Germany), H. Popper (Graz, Austria), J. Meyer (Munich, Germany)
| |
A single center experience of rituximab for anti synthetase syndrome associated interstitial lung disease (ASS-ILD)
A. Rathnapala (Welisara, Sri Lanka), L. Wing (Oxford, United Kingdom), R. Benamore (Oxford, United Kingdom), J. David (Oxford, United Kingdom), R. Hoyles (Oxford, United Kingdom)
| |
Diagnosing Sjogrën’ syndrome in patients with Interstitial Lung Disease by minor salivary gland biopsy.
P. Millan Billi (Barcelona, Spain), I. Castellvi (Barcelona, Spain), S. Barril Farre (Lleida, Spain), H. Park (Barcelona, Spain), L. Martinez Martinez (Barcelona, Spain), L. Lopez Vilaro (Barcelona, Spain), T. Fraquet Casas (Barcelona, Spain), F. Aparicio (Barcelona, Spain), O. Sibila Vidal (Barcelona, Spain), H. Corominas (Barcelona, Spain), D. Castillo Villegas (Barcelona, Spain)
| |
Induced sputum in systemic sclerosis: A new potential for biomarkers in SSc
P. Jacquerie (Liège, Belgium), B. André (Liège, Belgium), M. Henquet (Liège, Belgium), C. Moermans (Liège, Belgium), D. De Seny (Liège, Belgium), F. Gester (Liège, Belgium), R. Louis (Liège, Belgium), M. Malaise (Liège, Belgium), J. Guiot (Liège, Belgium)
| |
Bronchoalveolar lavage fluid cytokines in the assessment of interstitial lung disease in systemic sclerosis: a prospective study
S. Mittal (New Delhi, India), U. Kumar (New Delhi, India), R. Guleria (New Delhi, India), A. Mohan (New Delhi, India), K. Madan (New Delhi, India), A. Bhalla (New Delhi, India), S. Mathur (New Delhi, India)
| |
Interstitial pneumonia with autoimmune features associated with myositis autoantibodies: clinical characteristics from a multicenter Latin-American cohort.
J. Juárez León (Ciudad de México, Mexico), M. Alberti (Buenos Aires, Argentina), V. Wolff (Santiago de Chile, Chile), F. Reyes (Santiago de Chile, Chile), F. Paulin (Buenos Aires, Argentina), L. Fassola (Buenos Aires, Argentina), F. Caro (Buenos Aires, Argentina), G. Carballo (Buenos Aires, Argentina), T. Palavecino (Santiago de Chile, Chile), J. Díaz (Santiago de Chile, Chile), I. Buendía Roldán (Ciudad de México, Mexico), M. Mejía (Ciudad de México, Mexico), M. Florenzano (Santiago de Chile, Chile), J. Rojas Serrano (Ciudad de México, Mexico)
| |
Peptide ToAP3 from T. obscurus interferes with idiopathic pulmonary fibrosis progression in murine model.
K. Smidt Simon (Brasília, Brazil), C. Melo-Silva (Brasília, Brazil), P. Veloso (Brasília, Brazil), L. Coelho (Brasília, Brazil), J. Longo (Brasília, Brazil), L. Vianna (Brasília, Brazil), V. Amado (Brasília, Brazil), A. Bocca (Brasília, Brazil)
| |
Multicenter Registry of Interstitial Lung Diseases in Brazil
M. Soares (São Paulo, Brazil), C. Pereira (São Paulo, Brazil), A. Botelho (São Paulo, Brazil), A. Gimenez (São Paulo, Brazil), B. Beraldo (São Paulo, Brazil), C. Ferraz (São Paulo, Brazil), E. Mancuzo (Belo Horizonte, Brazil), F. Machado (São Paulo, Brazil), F. Toledo (São Paulo, Brazil), G. Miranda (São Paulo, Brazil), M. Moreira (Goiânia, Brazil), M. Taube (São Paulo, Brazil), M. Castro (São Paulo, Brazil), M. Cerezoli (São Paulo, Brazil), R. Boaventura (São Paulo, Brazil), R. Tibana (São Paulo, Brazil), T. Prata (Belo Horizonte, Brazil), E. Coletta (São Paulo, Brazil), R. Ferreira (São Paulo, Brazil)
| |
Lung involvement in autoimmune liver diseases
M. Brovko (Moscow, Russian Federation), M. Kalashnikov (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), V. Sholomova (Moscow, Russian Federation), A. Yanakaewa (Moscow, Russian Federation), D. Konovalov (Moscow, Russian Federation), M. Lebedeva (Moscow, Russian Federation), T. Rosina (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation)
| |
Tomographic pattern and disease progress or mortality in familial pulmonary fibrosis
E. Viana Mancuzo (Belo Horizonte, Minas Gerais, Brasil, Brazil), D. Strela (Belo Horizonte, Minas Gerais, Brasil, Brazil), L. Ferreira Pereira (Belo Horizonte, Minas Gerais, Brasil, Brazil), R. De Amorim Correa (Belo Horizonte, Minas Gerais, Brasil, Brazil)
| |